|
|
Neurology Devices Market Outlook in Belgium to 2016 - Neurostimulation Devices, Interventional Neurology and Others
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
|||||||||||
| Zahlen und Fakten zur Studie: |
Will be delivered within two days. 124 Pages | |||||||||||
| Inhalt der Studie: |
Introduction
GlobalData’s medical device report, “Neurology Devices Market Outlook in Belgium to 2016 - Neurostimulation Devices, Interventional Neurology and Others” provides key market data on the .....
Introduction GlobalData’s medical device report, “Neurology Devices Market Outlook in Belgium to 2016 - Neurostimulation Devices, Interventional Neurology and Others” provides key market data on the Belgium Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within five market categories – CSF Management, Neurosurgical Products, Neurostimulation Devices, Interventional Neurology, and Radiosurgery. Segments include Hydrocephalus Shunts, Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Embolic Systems, Navigational Systems, CyberKnife Radiosurgery and Others. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Scope - Market size and company share data for Neurology Devices market categories – CSF Management, Neurosurgical Products, Neurostimulation Devices, Interventional Neurology, and Radiosurgery - Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within five market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016. Segments include Hydrocephalus Shunts, Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Embolic Systems, Navigational Systems, CyberKnife Radiosurgery and Others. - 2009 company shares and distribution shares data for each of the five market categories. - Global corporate-level profiles of key companies operating within the Belgium Neurology Devices market. - Key players covered include Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., Cordis Corporation, Cyberonics, Inc. and others. Highlights Reasons to buy - Develop business strategies by identifying the key market categories and segments poised for strong growth. - Explore investment opportunites in the market. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the competitive landscape. - Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize. Report Highlights Medtronic, Inc. Boston Scientific Corporation St. Jude Medical, Inc. Cordis Corporation ev3 Inc. Cyberonics, Inc. B. Braun Melsungen AG Micrus Endovascular Corporation Integra LifeSciences Holdings Corporation KARL STORZ GmbH & Co. KG Terumo Corporation Codman & Shurtleff, Inc. VYGON Neuro [Studien Infos ausblenden] |
|||||||||||
|
TABLE OF CONTENTS 1 Table of Contents 2 1.1 List of Tables 6 1.2 List of Figures 8 2 Introduction 10 2.1 What is This Report About? 10 3 Neurology Devices In Belgium 11 3.1 Neurology Devices, Market Segmentation 11 3.2 Neurology Devices, Belgium, Overall Revenue ($m), 2002-2016 12 3.3 Neurology Devices Market, Belgium, Revenue Mix ($m), 2009 14 3.4 Neurology Devices Market, Belgium, Category Contribution (%), 2009 15 3.5 Neurology Devices, Belgium, Category Volume (Units), 2002-2016 22 3.6 Neurology Devices, Belgium, Company Share (2008-2009) 27 4 CSF Management In Belgium 29 4.1 CSF Management, Market Segmentation 29 4.2 CSF ManagementMarket, Belgium, Revenue Mix ($m), 2009 30 4.3 CSF Management Market, Belgium, Segment Contribution (%), 2009 31 4.4 CSF Management Overall Revenue (2002-2016) 32 4.5 CSF Management Overall Volume (2002-2016) 36 4.6 CSF Management Average Price (2002-2016) 40 4.7 CSF Management Distribution Share (2008-2009) 41 4.8 CSF Management, Belgium, Company Share (2008-2009) 42 5 Interventional Neurology In Belgium 44 5.1 Interventional Neurology, Market Segmentation 44 5.2 Interventional Neurology Market, Belgium, Revenue Mix ($m), 2009 45 5.3 Interventional Neurology Market, Belgium, Segment Contribution (%), 2009 46 5.4 Interventional Neurology Overall Revenue (2002-2016) 47 5.4.1 Embolic Systems Revenue (2002-2016) 51 5.4.2 Navigational Systems Revenue (2002-2016) 55 5.5 Interventional Neurology Overall Volume (2002-2016) 59 5.5.1 Embolic Systems Volume (2002-2016) 63 5.5.2 Navigational SystemsVolume (2002-2016) 67 5.6 Interventional Neurology Average Price (2002-2016) 71 5.7 Interventional Neurology Distribution Share (2008-2009) 72 5.8 Interventional Neurology, Belgium, Company Share (2008-2009) 73 6 Neurostimulation Devices In Belgium 75 6.1 Neurostimulation Devices, Market Segmentation 75 6.2 Neurostimulation Devices Market, Belgium, Revenue Mix ($m), 2009 76 6.3 Neurostimulation Devices Market, Belgium, Segment Contribution (%), 2009 77 6.4 Neurostimulation Devices Overall Revenue (2002-2016) 78 6.5 Neurostimulation Devices Overall Volume (2002-2016) 82 6.6 Neurostimulation Devices Average Price (2002-2016) 86 6.7 Neurostimulation Devices Distribution Share (2008-2009) 87 6.8 Neurostimulation Devices, Belgium, Company Share (2008-2009) 88 7 Neurosurgical Products In Belgium 90 7.1 Neurosurgical Products Overall Revenue (2002-2016) 90 7.2 Neurosurgical Products Overall Volume (2002-2016) 92 7.3 Neurosurgical Products Average Price (2002-2016) 94 7.4 Neurosurgical Products Distribution Share (2008-2009) 95 7.5 Neurosurgical Products, Belgium, Company Share (2008-2009) 96 8 Radiosurgery In Belgium 98 8.1 Radiosurgery, Market Segmentation 98 8.2 Radiosurgery Overall Revenue (2002-2016) 99 8.3 Radiosurgery Overall Volume (2002-2016) 100 8.4 Radiosurgery Average Price (2002-2016) 101 8.5 Radiosurgery, Belgium, Company Share (2008) 102 9 Overview of Key Companies in Belgium Neurology Devices Market 103 9.1 Medtronic, Inc. 103 9.1.1 Company Overview 103 9.1.2 Share in the Belgium Neurology Devices Market 103 9.2 Boston Scientific Corporation 104 9.2.1 Company Overview 104 9.2.2 Share in the Belgium Neurology Devices Market 104 9.3 St. Jude Medical, Inc. 105 9.3.1 Company Overview 105 9.3.2 Share in the Belgium Neurology Devices Market 105 9.4 Cordis Corporation 106 9.4.1 Company Overview 106 9.4.2 Share in the Belgium Neurology Devices Market 106 9.5 ev3 Inc. 107 9.5.1 Company Overview 107 9.5.2 Share in the Belgium Neurology Devices Market 107 9.6 Cyberonics, Inc. 108 9.6.1 Company Overview 108 9.6.2 Share in the Belgium Neurology Devices Market 108 9.7 B. Braun Melsungen AG 109 9.7.1 Company Overview 109 9.8 Micrus Endovascular Corporation 109 9.8.1 Company Overview 109 9.9 Integra LifeSciences Holdings Corporation 110 9.9.1 Company Overview 110 9.10 KARL STORZ GmbH & Co. KG 110 9.10.1 Company Overview 110 9.11 Terumo Corporation 110 9.11.1 Company Overview 110 9.12 Codman & Shurtleff, Inc. 111 9.12.1 Company Overview 111 9.13 VYGON Neuro 111 9.13.1 Company Overview 111 10 Neurology Devices Market Pipeline Products 112 11 Appendix 117 11.1 Definitions of Markets Covered in the Report 118 11.1.1 Neurology Devices 118 11.2 Research Methodology 121 11.3 Secondary Research 121 11.4 Primary Research 122 11.5 Models 122 11.6 Forecasts 123 11.7 Expert Panels 123 11.8 GlobalData Consulting 123 11.9 Currency Conversion 123 11.10 Contact Us 124 11.11 Disclaimer 124 [Inhaltsverzeichnis ausblenden] |
||||||||||||
|
LIST OF TABLES 1.1 List of Tables Table 1: Neurology Devices, Belgium, Overall Revenue ($m), 2002-2016 13 Table 2: Neurology Devices Market, Belgium, Category Contribution (%), 2009 15 Table 3: Neurology Devices, Belgium, Cross-Category Analysis, 2002-2016 17 Table 4: Neurology Devices, Belgium, Overall Revenue ($m), Historic, 2002-2009 19 Table 5: Neurology Devices, Belgium, Overall Revenue ($m), Forecast, 2009-2016 21 Table 6: Neurology Devices, Belgium, Category Volume (Units), 2002-2016 22 Table 7: Neurology Devices, Belgium, Category Volume (Units), Historic, 2002-2009 24 Table 8: Neurology Devices, Belgium, Category Volume (Units), Forecast, 2009-2016 26 Table 9: Neurology Devices, Belgium, Company Share by Revenue ($m), 2008-2009 28 Table 10: CSF Management Market, Belgium, Segment Contribution (%), 2009 31 Table 11: CSF Management, Belgium, Revenue ($m) by Segment, Historic, 2002-2009 33 Table 12: CSF Management, Belgium, Revenue ($m) by Segment, Forecast, 2009-2016 35 Table 13: CSF Management, Belgium, Volume (Units) by Segment, Historic, 2002-2009 37 Table 14: CSF Management, Belgium, Volume (Units) by Segment, Forecast, 2009-2016 39 Table 15: CSF Management, Belgium, Average Price ($), Historic, 2002-2009 40 Table 16: CSF Management, Belgium, Average Price ($), Forecast, 2009-2016 40 Table 17: CSF Management, Belgium, Distribution Share by Revenue ($m), 2008-2009 41 Table 18: CSF Management, Belgium, Company Share by Revenue ($m), 2008-2009 43 Table 19: Interventional Neurology Market, Belgium, Segment Contribution (%), 2009 46 Table 20: Interventional Neurology, Belgium, Revenue ($m) by Segment, Historic, 2002-2009 48 Table 21: Interventional Neurology, Belgium, Revenue ($m) by Segment, Forecast, 2009-2016 50 Table 22: Embolic Systems, Belgium, Revenue ($m) by Sub-Segment, Historic, 2002-2009 52 Table 23: Embolic Systems, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 54 Table 24: Navigational Systems, Belgium, Revenue ($m) by Sub-Segment, Historic, 2002-2009 56 Table 25: Navigational Systems, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 58 Table 26: Interventional Neurology, Belgium, Volume (Units) by Segment, Historic, 2002-2009 60 Table 27: Interventional Neurology, Belgium, Volume (Units) by Segment, Forecast, 2009-2016 62 Table 28: Embolic Systems, Belgium, Volume (Units) by Sub-Segment, Historic, 2002-2009 64 Table 29: Embolic Systems, Belgium, Volume (Units) by Sub-Segment, Forecast, 2009-2016 66 Table 30: Navigational Systems, Belgium, Volume (Units) by Sub-Segment, Historic, 2002-2009 68 Table 31: Navigational Systems, Belgium, Volume (Units) by Sub-Segment, Forecast, 2009-2016 70 Table 32: Interventional Neurology, Belgium, Average Price ($), Historic, 2002-2009 71 Table 33: Interventional Neurology, Belgium, Average Price ($), Forecast, 2009-2016 71 Table 34: Interventional Neurology, Belgium, Distribution Share by Revenue ($m), 2008-2009 72 Table 35: Interventional Neurology, Belgium, Company Share by Revenue ($m), 2008-2009 74 Table 36: Neurostimulation Devices Market, Belgium, Segment Contribution (%), 2009 77 Table 37: Neurostimulation Devices, Belgium, Revenue ($m) by Segment, Historic, 2002-2009 79 Table 38: Neurostimulation Devices, Belgium, Revenue ($m) by Segment, Forecast, 2009-2016 81 Table 39: Neurostimulation Devices, Belgium, Volume (Units) by Segment, Historic, 2002-2009 83 Table 40: Neurostimulation Devices, Belgium, Volume (Units) by Segment, Forecast, 2009-2016 85 Table 41: Neurostimulation Devices, Belgium, Average Price ($), Historic, 2002-2009 86 Table 42: Neurostimulation Devices, Belgium, Average Price ($), Forecast, 2009-2016 86 Table 43: Neurostimulation Devices, Belgium, Distribution Share by Revenue ($m), 2008-2009 87 Table 44: Neurostimulation Devices, Belgium, Company Share by Revenue ($m), 2008-2009 89 Table 45: Neurosurgical Products, Belgium, Revenue ($m), Historic, 2002-2009 90 Table 46: Neurosurgical Products, Belgium, Revenue ($m), Forecast, 2009-2016 91 Table 47: Neurosurgical Products, Belgium, Volume (Units), Historic, 2002-2009 92 Table 48: Neurosurgical Products, Belgium, Volume (Units), Forecast, 2009-2016 93 Table 49: Neurosurgical Products, Belgium, Average Price ($), Historic, 2002-2009 94 Table 50: Neurosurgical Products, Belgium, Average Price ($), Forecast, 2009-2016 94 Table 51: Neurosurgical Products, Belgium, Distribution Share by Revenue ($m), 2008-2009 95 Table 52: Neurosurgical Products, Belgium, Company Share by Revenue ($m), 2008-2009 97 Table 53: Radiosurgery, Belgium, Revenue ($m) by Segment, Historic, 2002-2009 99 Table 54: Radiosurgery, Belgium, Volume (Units) by Segment, Historic, 2002-2009 100 Table 55: Radiosurgery, Belgium, Average Price ($), Historic, 2002-2009 101 Table 56: Radiosurgery, Belgium, Company Share by Revenue ($m), 2008-2008 102 Table 57: Neurology Devices Market Pipeline Products 112 Table 58: USD to Local Currency, Belgium, Average Actual Rate 2002-2009 123 LIST OF FIGURES 1.2 List of Figures Figure 1: Neurology Devices, Market Segmentation 11 Figure 2: Neurology Devices, Belgium, Overall Revenue ($m), 2002-2016 12 Figure 3: Neurology Devices Market, Belgium, Revenue Mix ($m), 2009 14 Figure 4: Neurology Devices Market, Belgium, Category Contribution (%), 2009 15 Figure 5: Neurology Devices, Belgium, Cross-Category Analysis, 2002-2016 16 Figure 6: Neurology Devices, Belgium, Overall Revenue ($m), Historic, 2002-2009 18 Figure 7: Neurology Devices, Belgium, Overall Revenue ($m), Forecast, 2009-2016 20 Figure 8: Neurology Devices, Belgium, Category Volume (Units), 2002-2016 22 Figure 9: Neurology Devices, Belgium, Category Volume (Units), Historic, 2002-2009 23 Figure 10: Neurology Devices, Belgium, Category Volume (Units), Forecast, 2009-2016 25 Figure 11: Neurology Devices, Belgium, Company Share (%), 2009 27 Figure 12: CSF Management, Market Segmentation 29 Figure 13: CSF Management Market, Belgium, Revenue Mix ($m), 2009 30 Figure 14: CSF Management Market, Belgium, Segment Contribution (%), 2009 31 Figure 15: CSF Management, Belgium, Revenue ($m) by Segment, Historic, 2002-2009 32 Figure 16: CSF Management, Belgium, Revenue ($m) by Segment, Forecast, 2009-2016 34 Figure 17: CSF Management, Belgium, Volume (Units) by Segment, Historic, 2002-2009 36 Figure 18: CSF Management, Belgium, Volume (Units) by Segment, Forecast, 2009-2016 38 Figure 19: CSF Management, Belgium, Company Share (%), 2009 42 Figure 20: Interventional Neurology, Market Segmentation 44 Figure 21: Interventional Neurology Market, Belgium, Revenue Mix ($m), 2009 45 Figure 22: Interventional Neurology Market, Belgium, Segment Contribution (%), 2009 46 Figure 23: Interventional Neurology, Belgium, Revenue ($m) by Segment, Historic, 2002-2009 47 Figure 24: Interventional Neurology, Belgium, Revenue ($m) by Segment, Forecast, 2009-2016 49 Figure 25: Embolic Systems, Belgium, Revenue ($m) by Sub-Segment, Historic, 2002-2009 51 Figure 26: Embolic Systems, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 53 Figure 27: Navigational Systems, Belgium, Revenue ($m) by Sub-Segment, Historic, 2002-2009 55 Figure 28: Navigational Systems, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 57 Figure 29: Interventional Neurology, Belgium, Volume (Units) by Segment, Historic, 2002-2009 59 Figure 30: Interventional Neurology, Belgium, Volume (Units) by Segment, Forecast, 2009-2016 61 Figure 31: Embolic Systems, Belgium, Volume (Units) by Sub-Segment, Historic, 2002-2009 63 Figure 32: Embolic Systems, Belgium, Volume (Units) by Sub-Segment, Forecast, 2009-2016 65 Figure 33: Navigational Systems, Belgium, Volume (Units) by Sub-Segment, Historic, 2002-2009 67 Figure 34: Navigational Systems, Belgium, Volume (Units) by Sub-Segment, Forecast, 2009-2016 69 Figure 35: Interventional Neurology, Belgium, Company Share (%), 2009 73 Figure 36: Neurostimulation Devices, Market Segmentation 75 Figure 37: Neurostimulation Devices Market, Belgium, Revenue Mix ($m), 2009 76 Figure 38: Neurostimulation Devices Market, Belgium, Segment Contribution (%), 2009 77 Figure 39: Neurostimulation Devices, Belgium, Revenue ($m) by Segment, Historic, 2002-2009 78 Figure 40: Neurostimulation Devices, Belgium, Revenue ($m) by Segment, Forecast, 2009-2016 80 Figure 41: Neurostimulation Devices, Belgium, Volume (Units) by Segment, Historic, 2002-2009 82 Figure 42: Neurostimulation Devices, Belgium, Volume (Units) by Segment, Forecast, 2009-2016 84 Figure 43: Neurostimulation Devices, Belgium, Company Share (%), 2009 88 Figure 44: Neurosurgical Products, Belgium, Revenue ($m), Historic, 2002-2009 90 Figure 45: Neurosurgical Products, Belgium, Revenue ($m), Forecast, 2009-2016 91 Figure 46: Neurosurgical Products, Belgium, Volume (Units), Historic, 2002-2009 92 Figure 47: Neurosurgical Products, Belgium, Volume (Units), Forecast, 2009-2016 93 Figure 48: Neurosurgical Products, Belgium, Company Share (%), 2009 96 Figure 49: Radiosurgery, Market Segmentation 98 Figure 50: Medtronic, Inc., Company Share (%),Belgium Neurology Devices Market, 2009 103 Figure 51: Boston Scientific Corporation, Company Share (%),Belgium Neurology Devices Market, 2009 104 Figure 52: St. Jude Medical, Inc., Company Share (%),Belgium Neurology Devices Market, 2009 105 Figure 53: Cordis Corporation, Company Share (%),Belgium Neurology Devices Market, 2009 106 Figure 54: ev3 Inc., Company Share (%),Belgium Neurology Devices Market, 2009 107 Figure 55: Cyberonics, Inc., Company Share (%),Belgium Neurology Devices Market, 2009 108 [Tabellenverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||


